Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Cancers|May 13, 2023
The Role of HER2 Status in the Biliary Tract CancersRuveyda Ayasun, Muhammet Ozer, Ilyas SahinLiver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 13, 2024
Immune checkpoint inhibitors in the posttransplant landscape of HCC: A systematic literature reviewDoga Kahramangil, Ali Zarrinpar, Ilyas SahinInternational Journal of Molecular Sciences|November 13, 2021
Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other CancersIlyas Sahin, Andrew George, Attila A SeyhanCancer Biology & Therapy|January 16, 2018
Androgen receptor-independent prostate cancer: an emerging clinical entityIlyas Sahin, Anthony E Mega, Benedito A CarneiroJournal of Chemotherapy (Florence, Italy)|May 16, 2024
Durable pembrolizumab response in metastatic MSS ARID1A-mutant undifferentiated carcinoma of the esophagusZohaib Ijaz, Doga Kahramangil, Kriti Gera, et al.Oncotargets and Therapy|February 26, 2019
Mogamulizumab: a new tool for management of cutaneous T-cell lymphomaThomas A Ollila, Ilyas Sahin, Adam J OlszewskiJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2023
Updates in the use of targeted therapies for the treatment of cholangiocarcinomaEmma Lodl, Brian Ramnaraign, Ilyas Sahin, et al.Journal of Hepatocellular Carcinoma|June 4, 2024
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular CarcinomaFahreddin Palaz, Mehmet Ozsoz, Ali Zarrinpar, et al.Hepatology (Baltimore, Md.)|January 21, 2023
Mechanisms of drug resistance in HCCAlexandra D Ladd, Sergio Duarte, Ilyas Sahin, et al.Integrative Cancer Therapies|March 23, 2019
Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer TherapyIlyas Sahin, Birdal Bilir, Shakir Ali, et al.Pageof 6